Literature DB >> 1901892

Serologic and chemical differentiation of human lambda III light chain variable regions.

M Eulitz1, C Murphy, D T Weiss, A Solomon.   

Abstract

Human lambda L chains of a major V lambda subgroup, V lambda III, have been differentiated serologically and chemically into three V lambda III sub-subgroups designated V lambda IIIa, V lambda IIIb, and V lambda IIIc. Antisera prepared against lambda III Bence Jones proteins were obtained that recognized distinctive V lambda III-related epitopes expressed by monoclonal lambda III L chains. After appropriate absorption, these reagents were rendered specific for three distinct populations of lambda III proteins--lambda IIIa, lambda IIIb, and lambda IIIc. The antisera were used in comparative immunodiffusion analyses of 28 monoclonal lambda III L chains, 10 of which were classified as lambda IIIa, 4 as lambda IIIb, and 14 as lambda IIIc. The isotypic nature of the three lambda III sub-subgroups was demonstrated serologically through analyses of lambda-chains derived from the serum IgG molecules of normal individuals. The amino acid sequences of five serologically classified lambda III chains, which included members of the three V lambda III sub-subgroups, had been previously determined. This information, in addition to our establishment of the complete (or virtually complete) V region sequence of 15 and the partial sequence of eight other lambda IIIa, lambda IIIb, and lambda IIIc proteins, made it possible to correlate chemical data with serologic classification. Proteins within each of the three serologically-classified lambda III sub-subgroups typically possessed a high degree (approximately 83%) of intra-sub-subgroup sequence homology that included both framework and complementarity determining region residues. Furthermore, within the framework and complementarity determining regions, sub-subgroup-specific residues were identified. Taken together, these data reveal that the human V lambda III genome consists of (at least) three distinct V lambda IIIa, V lambda IIIb, and V lambda IIIc germline genes that encode for lambda IIIa, lambda IIIb, and lambda IIIc L chains, respectively.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1901892

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Crystallization of a complex between the Fab fragment of a human immunoglobulin M (IgM) rheumatoid factor (RF-AN) and the Fc fragment of human IgG4.

Authors:  M K Sohi; A L Corper; T Wan; M Steinitz; R Jefferis; D Beale; M He; A Feinstein; B J Sutton; M J Taussig
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

Review 2.  Structural and functional properties of human lambda-light-chain variable-region subgroups.

Authors:  A Solomon; D T Weiss
Journal:  Clin Diagn Lab Immunol       Date:  1995-07

3.  Elicitor-Induced Spruce Stress Lignin (Structural Similarity to Early Developmental Lignins).

Authors:  B. M. Lange; C. Lapierre; H. Sandermann
Journal:  Plant Physiol       Date:  1995-07       Impact factor: 8.340

4.  Recombinant immunoglobulin variable domains generated from synthetic genes provide a system for in vitro characterization of light-chain amyloid proteins.

Authors:  P W Stevens; R Raffen; D K Hanson; Y L Deng; M Berrios-Hammond; F A Westholm; C Murphy; M Eulitz; R Wetzel; A Solomon
Journal:  Protein Sci       Date:  1995-03       Impact factor: 6.725

5.  Differential recruitment efficacy of patient-derived amyloidogenic and myeloma light chain proteins by synthetic fibrils-A metric for predicting amyloid propensity.

Authors:  Emily B Martin; Angela Williams; Craig Wooliver; R Eric Heidel; Sarah Adams; John Dunlap; Marina Ramirez-Alvarado; Luis M Blancas-Mejia; Ronald H Lands; Stephen J Kennel; Jonathan S Wall
Journal:  PLoS One       Date:  2017-03-28       Impact factor: 3.240

6.  Human rheumatoid factors with restrictive specificity for rabbit immunoglobulin G: auto- and multi-reactivity, diverse VH gene segment usage and preferential usage of V lambda IIIb.

Authors:  Q Fang; C C Kannapell; F Gaskin; A Solomon; W J Koopman; S M Fu
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.